Study Identifies Fibroblast Growth Factor 18 as an Ovarian Cancer Biomarker
Ovarian cancer is one of the leading causes of cancer-related death in women and is often not detected until the later stages of disease, which contributes to poor prognosis. Biomarkers that can be used for early diagnosis and outcome have been identified; however, many of these have not been evaluated at the biological and clinical levels.
In this issue of the Journal of Clinical Investigation, Michael Birrer and colleagues at Massachusetts General Hospital identify fibroblast growth factor 18 (FGF18) as a predictive marker for poor overall survival in ovarian cancer patients. Overexpression of the gene encoding FGF18 was associated with enhanced tumor blood vessel formation and expression of cancer promoting cytokines.
These data indicate that further studies on the predictive potential FGF18 and its use as a therapeutic target in ovarian cancer are warranted.
Endometriosis: Growing Cause of Infertility in Womenprevious page
Association between Eating Disorders and Reproductive Health Problemsnext page
- Tubal blockage with hydrosalpinx can be cured by TCM shortly
- Fuyan Pill Helps A woman with Adenomyosis Get Pregnant
- A Woman with Hydrosalpinx Is Cured with Fuyan pill
- Pelvic Inflammatory Disease Testimonials
- Irregular Vaginal Bleeding and Endometrial Thickening Cured by Fuyan Pill
- Pruritus Vulvae and Frequent Urination: Mycoplasma Infection Cured after 2 Courses
- UU, MH and CT Turned Negative after 1 Course